Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

NCT03895229 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03895229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03895229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin
Lead sponsor
Ain Shams University
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2018
Completion date
October 26, 2018
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, pharmacodynamics, pharmacokinetics